Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of antibiotics, corticosteroids, and microbiota on immunotherapy efficacy in patients with non-small cell lung cancer.
Zapata-García M, Moratiel-Pellitero A, Isla D, Gálvez E, Gascón-Ruiz M, Sesma A, Barbero R, Galeano J, Del Campo R, Ocáriz M, Quílez E, Cruellas M, Remírez-Labrada A, Pardo J, Martínez-Lostao L, Domingo MP, Esteban P, Torres-Ramón I, Yubero A, Paño JR, Lastra R. Zapata-García M, et al. Among authors: yubero a. Heliyon. 2024 Jul 1;10(13):e33684. doi: 10.1016/j.heliyon.2024.e33684. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39050456 Free PMC article.
XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer.
Feliu J, Salud A, Escudero P, Lopez-Gómez L, Bolaños M, Galán A, Vicent JM, Yubero A, Losa F, De Castro J, de Mon MA, Casado E, González-Barón M. Feliu J, et al. Among authors: yubero a. Br J Cancer. 2006 Apr 10;94(7):969-75. doi: 10.1038/sj.bjc.6603047. Br J Cancer. 2006. PMID: 16552438 Free PMC article. Clinical Trial.
Intratumoral Versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?
Gascón M, Isla D, Cruellas M, Gálvez EM, Lastra R, Ocáriz M, Paño JR, Ramírez A, Sesma A, Torres-Ramón I, Yubero A, Pardo J, Martínez-Lostao L. Gascón M, et al. Among authors: yubero a. Cells. 2020 Jun 22;9(6):1525. doi: 10.3390/cells9061525. Cells. 2020. PMID: 32580514 Free PMC article. Review.
From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with Immunotherapy.
Sesma A, Pardo J, Cruellas M, Gálvez EM, Gascón M, Isla D, Martínez-Lostao L, Ocáriz M, Paño JR, Quílez E, Ramírez A, Torres-Ramón I, Yubero A, Zapata M, Lastra R. Sesma A, et al. Among authors: yubero a. Cancers (Basel). 2020 Oct 14;12(10):2974. doi: 10.3390/cancers12102974. Cancers (Basel). 2020. PMID: 33066479 Free PMC article. Review.
Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy.
Ocáriz-Díez M, Cruellas M, Gascón M, Lastra R, Martínez-Lostao L, Ramírez-Labrada A, Paño JR, Sesma A, Torres I, Yubero A, Pardo J, Isla D, Gálvez EM. Ocáriz-Díez M, et al. Among authors: yubero a. Front Oncol. 2020 Sep 24;10:568939. doi: 10.3389/fonc.2020.568939. eCollection 2020. Front Oncol. 2020. PMID: 33117698 Free PMC article. Review.
How Could Antibiotics, Probiotics, and Corticoids Modify Microbiota and Its Influence in Cancer Immune Checkpoint Inhibitors: A Review.
Cruellas M, Yubero A, Zapata M, Galvez EM, Gascón M, Isla D, Lastra R, Martínez-Lostao L, Ocariz M, Pardo J, Ramírez A, Sesma A, Torres-Ramón I, Paño JR. Cruellas M, et al. Among authors: yubero a. Infect Immun. 2021 Aug 16;89(9):e0066520. doi: 10.1128/IAI.00665-20. Epub 2021 Aug 16. Infect Immun. 2021. PMID: 33526567 Free PMC article. Review.
A Subset of PD-1-Expressing CD56bright NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer.
Gascón-Ruiz M, Ramírez-Labrada A, Lastra R, Martínez-Lostao L, Paño-Pardo JR, Sesma A, Zapata-García M, Moratiel A, Quílez E, Torres-Ramón I, Yubero A, Domingo MP, Esteban P, Gálvez EM, Pardo J, Isla D. Gascón-Ruiz M, et al. Among authors: yubero a. Cancers (Basel). 2023 Jan 4;15(2):329. doi: 10.3390/cancers15020329. Cancers (Basel). 2023. PMID: 36672279 Free PMC article.
Biomarkers of Immunotherapy Response in Patients with Non-Small-Cell Lung Cancer: Microbiota Composition, Short-Chain Fatty Acids, and Intestinal Permeability.
Moratiel-Pellitero A, Zapata-García M, Gascón-Ruiz M, Sesma A, Quílez E, Ramirez-Labrada A, Martínez-Lostao L, Domingo MP, Esteban P, Yubero A, Barbero-Herranz R, Moreno-Blanco A, Paño JR, Lastra R, Pardo J, Isla D, Del Campo R, Gálvez E. Moratiel-Pellitero A, et al. Among authors: yubero a. Cancers (Basel). 2024 Mar 13;16(6):1144. doi: 10.3390/cancers16061144. Cancers (Basel). 2024. PMID: 38539479 Free PMC article.
Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer.
Sesma A, Pardo J, Isla D, M Gálvez E, Gascón-Ruiz M, Martínez-Lostao L, Moratiel A, Paño-Pardo JR, Quílez E, Torres-Ramón I, Yubero A, Zapata-García M, Domingo MP, Esteban P, Sanz Pamplona R, Lastra R, Ramírez-Labrada A. Sesma A, et al. Among authors: yubero a. Cancers (Basel). 2024 Aug 8;16(16):2798. doi: 10.3390/cancers16162798. Cancers (Basel). 2024. PMID: 39199571 Free PMC article.
First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis.
García-Alfonso P, Díaz-Rubio E, Abad A, Carrato A, Massutí B, Ortiz-Morales MJ, Manzano Mozo JL, Muñoz A, Durán G, Sastre J, Safont MJ, Ferreiro R, Rivera F, González E, Valladares-Ayerbes M, Grávalos C, Alonso-Orduña V, Viéitez JM, Yubero A, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD). García-Alfonso P, et al. Among authors: yubero a. Drugs Aging. 2021 Mar;38(3):219-231. doi: 10.1007/s40266-021-00834-w. Epub 2021 Feb 22. Drugs Aging. 2021. PMID: 33615402 Free PMC article.
34 results